Browse Data and Analysis
Filter
Search
- 12 results found
- (-) Fruits and Vegetables
- (-) Corn
- (-) Western Hemisphere
- (-) Trade Policy
- Clear all
The first commercial sales of products of a genetically engineered animal, the AquAdvantage salmon, occurred in Canada in 2017.
Brazil’s consumers have a budding appetite for higher-value food products as the country’s economy recovers from a historic recession and its middle class grows.
Costa Rican food processors and consumers trust and value food products that include U.S. raw materials and ingredients. Demand for quality ingredients has been steadily increasing...
Honduras allows commercial production of genetically engineered (GE) crops. As of October 2016, planted GE corn areas increased by 13 percent to 38,700 hectares from the previous year.
Agricultural biotechnology policy has not been a priority of Chile’s current administration. FAS/Santiago expects Chile’s agricultural biotechnology policies to remain unchanged.
On October 27, 2016, the Government of the Bolivarian Republic of Venezuela (GBRV) temporarily (one year) eliminated import tariffs and value added taxes for scarce agricultural products...
Central America and the Caribbean, with their close geographical and economic ties to the United States, have always been an important market for U.S. agricultural exports.
The U.S-Mexico ag trade relationship is broad and deep, with opportunities to further integrate our rural economies while supplying desired products to consumers in both countries year-round.
Although Ecuador maintains a number of anti-biotech laws and regulations, there is minimal enforcement, and trade in cotton and soybean products continues.
Guatemala, at present, allows the importation of genetically engineered (GE) agricultural and food products, but has not approved the use of GE plants for agricultural production.
Honduras is the only country in Central America that allows commercial production and field trials of agricultural biotech crops.
Recent high-profile activism against biotechnology has created uncertainty among those involved in production and research of biotechnology products in Costa Rica.